Adrenal insufficiency in liver disease - What is the evidence?

Journal of Hepatology

Volumn 47, Issue 3, 2007, Pages 418-423

  O'Beirne, James ^a   Holmes, Michael ^a   Agarwal, Banwari ^a   Bouloux, Pierre ^a   Shaw, Steve ^a   Patch, David ^a   Burroughs, Andrew ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Adrenal function; Cirrhosis; Liver failure; Synacthen

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLUDROCORTISONE; HYDROCORTISONE; PREDNISOLONE; TETRACOSACTIDE;

ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; BLOOD VESSEL TONE; CLINICAL TRIAL; DRUG INTOXICATION; HEART OUTPUT; HUMAN; HYDROCORTISONE RELEASE; INFECTION; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; LOW DRUG DOSE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK;

ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROCORTISONE; LIVER DISEASES; LIVER TRANSPLANTATION; PREVALENCE; SEPSIS; SHOCK, SEPTIC;

EID: 34547488467     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.06.008     Document Type: Review

References (40)

1. Blendis L., and Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 89 (2001) 221-231
2. Clemmesen O., Ott P., and Larsen F.S. Splanchnic metabolism in acute liver failure and sepsis. Curr Opin Crit Care 10 (2004) 152-155
3. Fiuza C., and Suffredini A.F. Human models of innate immunity: local and systemic inflammatory responses. J Endotoxin Res 7 (2001) 385-388
4. Antoniades C.G., Wendon J., and Vergani D. Paralysed monocytes in acute on chronic liver disease. J Hepatol 42 (2005) 163-165
5. Wasmuth H.E., Kunz D., Yagmur E., Timmer-Stranghoner A., Vidacek D., Siewert E., et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 42 (2005) 195-201
6. Annane D., Bellissant E., Bollaert P.E., Briegel J., Keh D., and Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329 (2004) 480
7. Hoen S., Mazoit J.X., Asehnoune K., Brailly-Tabard S., Benhamou D., Moine P., et al. Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 33 (2005) 2737-2743
8. Annane D., Sebille V., Troche G., Raphael J.C., Gajdos P., and Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283 (2000) 1038-1045
9. Minneci P.C., Deans K.J., Banks S.M., Eichacker P.Q., and Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141 (2004) 47-56
10. Harry R., Auzinger G., and Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 23 (2003) 71-77
11. Harry R., Auzinger G., and Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36 (2002) 395-402
12. Tsai M.H., Peng Y.S., Chen Y.C., Liu N.J., Ho Y.P., Fang J.T., et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 43 (2006) 673-681
13. Marik P.E., Gayowski T., and Starzl T.E. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 33 (2005) 1254-1259
14. Fernandez J., Escorsell A., Zabalza M., Felipe V., Navasa M., Mas A., et al. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 44 (2006) 1288-1295
15. Arlt W., and Stewart P.M. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am 34 (2005) 293-313 viii
16. Snijdewint F.G., Kapsenberg M.L., Wauben-Penris P.J., and Bos J.D. Corticosteroids class-dependently inhibit in vitro Th1- and Th2-type cytokine production. Immunopharmacology 29 (1995) 93-101
17. Cronstein B.N., Kimmel S.C., Levin R.I., Martiniuk F., and Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 89 (1992) 9991-9995
18. Yang S., and Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2 (2004) 1-12
19. Hellman A., and Lundberg D. Hemodynamic effects of high doses of corticosteroids. Acta Chir Scand Suppl 526 (1985) 13-18
20. Hinshaw L.B., Beller B.K., Chang A.C., Murray C.K., Flournoy D.J., Passey R.B., et al. Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock 16 (1985) 265-277
21. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 184 (1976) 333-341
22. Bone R.C., Fisher Jr. C.J., Clemmer T.P., Slotman G.J., Metz C.A., and Balk R.A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 (1987) 653-658
23. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987;317:659-65.
24. Bollaert P.E., Charpentier C., Levy B., Debouverie M., Audibert G., and Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26 (1998) 645-650
25. Briegel J., Forst H., Haller M., Schelling G., Kilger E., Kuprat G., et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27 (1999) 723-732
26. Baldwin W.A., and Allo M. Occult hypoadrenalism in critically ill patients. Arch Surg 128 (1993) 673-676
27. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
28. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
29. Marik P.E., and Zaloga G.P. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122 (2002) 1784-1796
30. Sekiyama K.D., Yoshiba M., and Thomson A.W. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98 (1994) 71-77
31. Marik P.E. Adrenal-exhaustion syndrome in patients with liver disease. Intensive Care Med 32 (2006) 275-280
32. Ho J.T., Al-Musalhi H., Chapman M.J., Quach T., Thomas P.D., Bagley C.J., et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 91 (2006) 105-114
33. Widmer I.E., Puder J.J., Konig C., Pargger H., Zerkowski H.R., Girard J., et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 90 (2005) 4579-4586
34. Iwasaki T., Tominaga M., Fukumoto T., Kusunoki N., Sugimoto T., Kido M., et al. Relative adrenal insufficiency manifested with multiple organ dysfunction in a liver transplant patient. Liver Transpl 12 (2006) 1896-1899
35. Borzio M., Salerno F., Piantoni L., Cazzaniga M., Angeli P., Bissoli F., et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33 (2001) 41-48
36. Ratanarat R., Cazzavillan S., Ricci Z., Rassu M., Segala C., de Cal M., et al. Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy. Blood Purif 25 (2007) 106-111
37. Yildiz O., Doganay M., Aygen B., Guven M., Kelestimur F., and Tutuu A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388]. Crit Care 6 (2002) 251-259
38. Keh D., Boehnke T., Weber-Cartens S., Schulz C., Ahlers O., Bercker S., et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167 (2003) 512-520
39. Oppert M., Schindler R., Husung C., Offermann K., Graf K.J., Boenisch O., et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 33 (2005) 2457-2464
40. Confalonieri M., Urbino R., Potena A., Piattella M., Parigi P., Puccio G., et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171 (2005) 242-248